The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

With the spread of the COVID-19 pandemic, how can we ensure the safety of our patients with cancer without delaying their treatment?

Available credits: 1.00

Time to complete: 60 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    With the relentless spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the incidence of Coronavirus disease 2019 (COVID-19) has quickly reached pandemic proportions. Individuals with cancer, chronic health conditions, the elderly, and specific ethnic populations appear to be uniquely vulnerable to more severe COVID-19. Cancer patients and providers must now chart a precarious course between avoiding death due to social distancing, and risking death due to cancer treatment being delayed or stopped. The plight of at-risk patients is exacerbated by racial disparities in care, illustrated by distressing reports of increased incidence and mortality among African Americans. Health care providers are uncertain how to proceed as the pandemic situation not only impacts their patients, but also takes a toll on them physically, socially, and emotionally.

    In this web-based, on-demand activity, the faculty panel will discuss, evaluate, and provide their interprofessional perspectives on cancer care, emergency medicine, and healthcare disparities as these clinical areas are impacted by COVID-19.

  • Learning Objectives

    At the conclusion of this activity, participants should be better able to:

    • Explain how to ensure the protection of health care workers providing care for patients with cancer and others at high risk of COVID-19
    • Provide optimal care for cancer patients and others at high risk of COVID-19 based on evolving data and recommendations
    • Recognize and address racial disparities and inequities in health care delivery that may be exacerbated by the COVID-19 pandemic
  • Target Audience

    This activity is intended for medical oncologists, oncology advanced practitioners (nurses, pharmacists, physician assistants), emergency medicine physicians, pathologists/lab professionals, and other healthcare professionals who treat or manage patients at high risk for COVID-19.

  • Faculty Disclosure

    Disclosure of Conflict of Interest 
    AXIS Medical Education requires instructors, planners, managers, reviewers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. 

    AXIS will identify, review, and resolve all conflicts of interestthat faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.

    The faculty/authors reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

    Pelin Cinar, MD, MS and Malika Fair, MD, MPH, FACEP have no real or apparent conflicts of interest to report. Robert Mocharnuk, MD, reported a financial interest/relationship or affiliation in the form of Common stock: Merck.

    The planners, managers and reviewers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: The following AXIS planners and managers, Linda Gracie-King, MS; Jocelyn Timko, BS; Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC;  Adrienne N. Nedved, MPA, PharmD, BCOP; and Dee Morgillo, MEd, MT(ASCP), CHCP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or  devices with any commercial interest of any amount during the past 12 months.  Robert Mocharnuk, MD, reported a financial interest/relationship or affiliation in the form of Common stock: Merck.

  • Accreditation and Credit Designation Statements

    Accreditation Statement

    ReachMD Healthcare ImageIn support of improving patient care, AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    ReachMD Healthcare ImageThis activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

    Credit Designation for Physicians
    AXIS Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ReachMD Healthcare ImageCredit Designation for Physician Assistants
    AXIS Medical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 12/03/2021. PAs should only claim credit commensurate with the extent of their participation. 

    Credit Designation for Pharmacists
    This knowledge-based activity is approved for 1.0 contact hour of continuing pharmacy education credit JA4008106-0000-20-058-H01-P.

    Credit Designation for Nursing
    AXIS Medical Education designates this continuing nursing education activity for 1.0 contact hours.
    Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

    Laboratory Professionals
    This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for 1.0 CMLE credit. ASCP CMLE credits are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program

  • Commercial Support

    This activity is supported by educational grants from Bristol-Myers Squibb Company and Daiichi Sankyo, Inc.

  • Terms of Use

    Disclosure of Unlabeled Use       
    This educational activity may contain discussion of agents that are not approved for use by the FDA and/or investigational (“off-label”) uses of agents that are approved by the FDA. The planners of this activity do not recommend the use of any agent outside of its labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each agent for information on its approved indications, contraindications, warnings, and other, related information.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    Method of Participation and Request for Credit:     
    To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately. For pharmacists, your record will be uploaded to CPE Monitor.

    There is no fee for this educational activity.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free